KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Short-term Investments (2016 - 2026)

Historic Short-term Investments for Exelixis (EXEL) over the last 17 years, with Q1 2026 value amounting to $576.6 million.

  • Exelixis' Short-term Investments fell 3549.59% to $576.6 million in Q1 2026 from the same period last year, while for Jan 2026 it was $576.6 million, marking a year-over-year decrease of 3549.59%. This contributed to the annual value of $576.6 million for FY2026, which is 3549.59% down from last year.
  • As of Q1 2026, Exelixis' Short-term Investments stood at $576.6 million, which was down 3549.59% from $612.2 million recorded in Q4 2025.
  • Over the past 5 years, Exelixis' Short-term Investments peaked at $930.8 million during Q3 2024, and registered a low of $576.6 million during Q1 2026.
  • Its 5-year average for Short-term Investments is $777.7 million, with a median of $802.9 million in 2023.
  • Per our database at Business Quant, Exelixis' Short-term Investments soared by 3174.5% in 2024 and then plummeted by 3549.59% in 2026.
  • Quarter analysis of 5 years shows Exelixis' Short-term Investments stood at $807.3 million in 2022, then fell by 9.29% to $732.3 million in 2023, then increased by 27.11% to $930.8 million in 2024, then tumbled by 34.23% to $612.2 million in 2025, then dropped by 5.82% to $576.6 million in 2026.
  • Its Short-term Investments stands at $576.6 million for Q1 2026, versus $612.2 million for Q4 2025 and $626.7 million for Q3 2025.